Position in ABBV
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$27,341,184
+$4,524,313 QoQ
Shares Held
108,652
+3.6% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.49%
of 13F equity value
Holder Rank
#515
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Derivatives in ABBV
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$125,820
PutShares
500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Merit Financial Group, LLC holds $230,161,066 across 16 Drug Manufacturers - General names. ABBV ranks #3 (11.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
45,883 | $55,033,445 | |
| 2 | JNJ |
Johnson & Johnson
|
209,661 | $53,247,600 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
108,652 | $27,341,184 | |
| 4 | MRK |
Merck & Co., Inc.
|
209,288 | $26,893,505 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
387,188 | $22,309,767 | |
| 6 | AMGN |
Amgen Inc
|
31,151 | $11,280,394 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
57,490 | $7,263,282 | |
| 8 | PFE |
Pfizer Inc
|
272,103 | $6,552,236 |
All Filings in ABBV
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $27,341,184 | 108,652 | Shares | Other | 2026-07-20 | |
| 2026-06-30 | $125,820 | 500 | Put | Sole | 2026-07-20 | |
| 2026-03-31 | $22,816,871 | 104,910 | Shares | Other | 2026-04-15 | |
| 2025-12-31 | $21,316,971 | 93,295 | Shares | Other | 2026-01-26 | |
| 2025-09-30 | $18,996,001 | 82,042 | Shares | Other | 2025-11-07 | |
| 2025-06-30 | $14,771,825 | 79,581 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $12,368,594 | 59,033 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $8,747,460 | 49,226 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $9,449,615 | 47,851 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $8,007,925 | 46,688 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $8,065,026 | 44,289 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $3,993,111 | 25,767 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $6,049,003 | 40,581 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $5,177,673 | 38,430 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $4,985,252 | 31,281 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $5,346,866 | 33,085 | Shares | Sole | 2023-01-13 | |
| 2022-09-30 | $4,221,038 | 31,451 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $6,048,288 | 39,490 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $2,226,905 | 13,737 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,745,983 | 12,895 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,414,391 | 13,112 | Shares | Sole | 2021-10-27 | |
| 2021-06-30 | $1,464,770 | 13,004 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,402,964 | 12,964 | Shares | Sole | 2021-05-18 | |
| 2020-12-31 | $1,286,657 | 12,008 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $876,513 | 10,007 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $808,414 | 8,234 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $532,339 | 6,987 | Shares | Sole | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||